Inside the research

Henry Schein, Inc.

HSIC Research profile · latest available data

Price overview

$86.37

▲ +0.84 (+1.0%)

52w hi$90.86
52w lo$62.03
Vol1.20M
As of25 Sep 2026

The Verdict

Hold

Our score +0.37

Short+0.31
Medium+0.46
Long+0.31

computed 2026-09-27

Key fundamentals

Henry Schein, Inc.

Healthcare · Medical Distribution

Market cap$9.63B
Enterprise value$14.85B
Trailing P/E25.18x
Forward P/E14.42x
EV / EBITDA13.75x
P / S (ttm)0.72x
Profit margin3.0%
Return on equity8.9%
Revenue growth+6.7%
Earnings growth+17.1%
Debt / equity80.73

Layer Breakdown

LayerRawContribution
Fundamental+0.23
Sector+0.08
Technical+0.19
Earnings+0.00
Sentiment+0.10

macro × 1.00 · 2026-09-27

Business overview

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

United States · www.henryschein.com

Risk Metrics

Beta vs SPX0.58
Corr SPX0.34
Annual vol27.0%
Annual ret+13.3%
Sharpe0.49
Max DD-24.3%

Window: 504 trading days (504 obs)

Analyst Coverage

Mean PT$87.21
High / Low$100.00 / $64.00
Median$88.00
Analysts14
Strong Buy4
Buy4
Hold7
Sell1
Strong Sell0

Recent rating actions

2026-05-06UBS→ Neutral
2026-05-06Mizuho→ Neutral
2026-04-24Morgan Stanley→ Underweight
2026-04-16BTIG→ Neutral
2026-04-15Citigroup→ Buy
2026-04-08Evercore ISI Group→ Outperform

Material Events

DateEvent8-K
2026-08-04Earnings Release, Exhibitsread
2026-07-30Officer / Director Change, Reg FD Disclosure…read
2026-05-22Shareholder Vote, Reg FD Disclosure…read
2026-05-05Earnings Release, Exhibitsread
2026-02-24Earnings Release, Exhibitsread
2026-01-12Officer / Director Change, Bylaws Amendment…read
2025-12-23Officer / Director Change, Exhibitsread
2025-12-23Material Agreement, Material Obligation…read
2025-12-09Material Agreementread
2025-11-04Earnings Release, Exhibitsread
2025-09-09Officer / Director Changeread
2025-08-05Earnings Release, Exhibitsread

Insider Trades

DateInsiderRoleActionSharesValue
2026-06-12DANIEL WILLIAM KDirectorGrant2.21K—
2026-03-19Popeck Thomas COfficer, CEO, Henry ScheiSell1.35K$98.63K
2026-03-17Ettinger Michael SOfficer, EVP & Chief OperGift1.00K—
2026-03-16Sheehy Christine ZayacOfficer, SVP, Chief HumaWithheld for tax463$34.54K
2026-03-16Popeck Thomas COfficer, CEO, Henry ScheiWithheld for tax587$43.80K
2026-03-16MLOTEK MARK EOfficer, EVP, Chief StratWithheld for tax5.93K$442.29K
2026-03-16Ettinger Michael SOfficer, EVP & Chief OperGift1.30K—
2026-03-16Ettinger Michael SOfficer, EVP & Chief OperWithheld for tax4.21K$314.41K
2026-03-16South Ronald N.Officer, SVP & Chief FinaWithheld for tax5.22K$389.17K

Flow & Concentration

Insider 180d net$0
Insider buys / sells0 / 0
Insider biasNeutral
13F holders8
Top-5 share99.9%
HHI4,027 (concentrated)

Top Holders

HolderValueShares
Vanguard Group Inc$875.84M11.59M
State Street Corp$332.79M4.40M
Fidelity / FMR LLC$300.26M3.97M
Citadel Advisors$24.19M320.05K
Millennium Management$16.07M212.68K
AQR Capital Management$1.25M16.57K
Bridgewater Associates$560.27K7.41K
T. Rowe Price Group$11.46K151.61K

As of 2025-12-31

SEC Filings

DateFormDoc
2026-08-048-Kview
2026-08-0410-Qview
2026-07-308-Kview
2026-06-1811-Kview
2026-06-154view
2026-05-283view
2026-05-224view
2026-05-228-Kview
2026-05-214view
2026-05-124view
2026-05-12DEFA14Aview
2026-05-0510-Qview
2026-05-058-Kview
2026-04-08DEFA14Aview
2026-04-08ARSview

The Long Run

FY 2010–2025 · 16 years

LineLatestCAGRTrend
Revenue$13.18B+13.8%
Gross profit$3.86B+4.8%
Operating income$621.00M+2.0%
Net income$398.00M+13.3%
Cash from ops$500.00M+2.1%

Indices

S&P 500

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$85.53$86.58$85.43$86.371.20M
Sep 24$84.50$85.92$84.38$85.531.38M
Sep 23$86.89$87.98$84.80$85.051.12M
Sep 22$85.93$87.64$85.58$87.431.07M
Sep 21$85.25$85.80$84.40$85.201.35M

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →